Early Stage Type 1 Diabetes
Following the publication of NICE TA1176 (Teplizumab for delaying the onset of Stage 3 Type 1 diabetes in people aged 8 years and older with Stage 2 Type 1 diabetes), developments in the Early-Stage Type 1 Diabetes (EST1D) landscape have progressed rapidly.
This section of the CYP National Diabetes Network website has been developed as a central resource for professionals working within children and young people’s diabetes services and adult diabetes services. It brings together Early-Stage T1 Diabetes information, guidance, resources and tools to support screening, monitoring, education and treatment pathways.
The site is organised into the following areas which will all be regularly updated as Early-Stage T1 Diabetes services develop:
Need to report missing information? If you identify any missing information or inaccuracies within this section, or would like any of your work included, please contact
jenny.foster5@nhs.net